Hormonal growth promotants (HGPs) are a group of veterinary medicines that pose
unique risks to New Zealand’s trade in primary produce. While it is legal to administer
HGPs to beef cattle in New Zealand, certain overseas countries have banned their use.
As New Zealand exports 80% of its beef produce, it became necessary to develop
regulatory controls to ensure HGP-treated beef is not sent to markets that only accept
non-HGP animal products.

Efficacy of a veterinary medicine is understood to be the degree to which the medicinal
claims made by the applicant have been justified and are likely to be attained under
practical field conditions within New Zealand. The need for an efficacy standard arises
from section 4 of the Agricultural Compounds and Veterinay Medicines (ACVM) Act
1997, which provides for prevention or management of risks associated with the use of
agricultural compounds:
• risks to trade in primary produce; and
• risks to animal welfare; and
• risks to agricultural security.

The purpose of the Agricultural Compounds and Veterinary Medicines (ACVM) Act 1997 is to:
(1) manage risks (public health, animal welfare, trade, agricultural security);
(2) ensure that the use of agricultural compounds does not result in breaches of domestic food residue standards;
(3) ensure the provision of sufficient consumer information about agricultural compounds.
Conditions are placed on product registrations to help achieve this purpose.

Verifiers have raised a number of questions regarding requirements where there are differences between Chinese and NZ legislation for the labelling of Infant Formula, Follow-on Formula and Formulated Supplementary Foods for Young Children. MPI have compiled the questions below along with the current legislation and guidance. Additional advice is also supplied for verifiers in response to the questions raised.

This document has been prepared by the Meat Industry Association (MIA) in partnership with MPI. It provides guidance to the meat industry on how to meet the requirements of the Animal Products (Risk Organism Response Plans) Notice 2008.

This generic HACCP plan is intended to serve as guide to assist poultry processing premises in the development of their own HACCP plans. It is very important that individual premises customise their HACCP plan to their specific product, process and premises.

1BT AGS application form that shows how to create a planting plan.

To help Regional Councils with the costs of coastal planning for aquaculture in accordance with the RMA and the New Zealand Coastal Policy Statement 2010 (NZCPS).

This organism causes the most commonly reported gastrointestinal disease in New Zealand. The two species Campylobacter jejuni and C. coli are most often associated with disease. It grows best in reduced oxygen atmospheres and only at temperatures
exceeding room temperature.

Guide to provide the options from RMP businesses who want to manage food safety of non-animal product foods within a Risk Management Programme.

Specifies requirements for controlling risk organisms and gives guidance on preparing Risk Organism Response Plans for processors of dairy material and product.

Note that the heat treatment criteria set out in clauses 10.1.1 and 10.1.2 of the guidelines no longer apply. Dairy manufacturers should refer to the appropriate chapter in the World Organisation for Animal Health’s Terrestrial Animal Health Code.